Urine Ammonium Concentrations and Cardiovascular and Kidney Outcomes in Systolic Blood Pressure Intervention Trial Participants with CKD
Open Access
- 22 July 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Kidney360
- Vol. 5 (8) , 1077-1086
Abstract
Key Points: Among nondiabetic individuals with hypertension and CKD, higher urine ammonium concentration is associated with higher risk of cardiovascular disease. Urine ammonium was not associated with all-cause mortality or CKD progression, AKI, or linear eGFR decline in the Systolic Blood Pressure Intervention Trial cohort. Background: Impaired urine ammonium excretion is common in CKD and may identify risk of metabolic acidosis earlier than reductions in serum bicarbonate or pH and thus may have associations with cardiovascular disease (CVD) outcomes. We evaluated the association of urine ammonium with CVD and kidney outcomes among persons with hypertension and nondiabetic CKD enrolled in a trial of BP reduction. Methods: We measured urine ammonium concentration in spot urine specimens collected at baseline among 2092 participants of the Systolic Blood Pressure Intervention Trial (SPRINT) with an eGFR 2. We used multivariable-adjusted Cox models to evaluate associations of urine ammonium concentration with the SPRINT CVD composite outcome (myocardial infarction, acute coronary syndrome, stroke, heart failure, or CVD death), all-cause mortality, the SPRINT kidney composite outcome (50% kidney function decline, ESKD, or transplant), and AKI. Results: At baseline, the mean (SD) age was 73 (9) years; 40% were female; and 25% were Black participants. The mean (SD) serum bicarbonate was 25.6 (2.8) mmol/L, median (interquartile range) urine ammonium concentration was 14.4 (9.5–23.1) mmol/L, and median (interquartile range) eGFR was 49 (39–55) ml/min per 1.73 m2. There were 255 CVD composite events, 143 deaths, 63 kidney composite events, and 146 AKI events during a median follow-up of 3.8 years. In multivariable models, each two-fold higher urinary ammonium concentration was associated with a 26% (95% confidence interval, 1.05 to 1.52) higher risk of the CVD composite, whereas there was no association with all-cause mortality, the SPRINT kidney composite outcome, or AKI. Conclusions: Among nondiabetic individuals with hypertension and CKD, higher urine ammonium concentration is associated with higher risk of CVD. Further studies are needed to evaluate this association in other cohorts.Keywords
Funding Information
- U.S. Department of Veterans Affairs (5IK2BX004986)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK098234)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK098234)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK110427)
- American Heart Association (14EIA18560026)
- Case Western Reserve University (UL1TR000439)
- Ohio State University (UL1RR025755)
- University of Pennsylvania (UL1RR024134)
- University of Pennsylvania (UL1TR000003)
- Boston University (UL1RR025771)
- Stanford University (UL1TR000093)
- Tufts University (UL1RR025752)
- Tufts University (UL1TR000073)
- Tufts University (UL1TR001064)
- University of Illinois System (UL1TR000050)
- University of Pittsburgh (UL1TR000005)
- University of Texas Southwestern (9U54TR000017)
- University of Utah (UL1TR000105-05)
- Vanderbilt University (UL1 TR000445)
- George Washington University (UL1TR000075)
- University of California, Davis (UL1 TR000002)
- University of Florida (UL1 TR000064)
- University of Michigan (UL1TR000433)
- Tulane University (P30GM103337 COBRE Award NIGMS)
- Wake Forest University (UL1TR001420)
- U.S. Department of Veterans Affairs (5IK2BX004986)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK098234)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK098234)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK110427)
- American Heart Association (14EIA18560026)
- Case Western Reserve University (UL1TR000439)
- Ohio State University (UL1RR025755)
- University of Pennsylvania (UL1RR024134)
- University of Pennsylvania (UL1TR000003)
- Boston University (UL1RR025771)
- Stanford University (UL1TR000093)
- Tufts University (UL1RR025752)
- Tufts University (UL1TR000073)
- Tufts University (UL1TR001064)
- University of Illinois System (UL1TR000050)
- University of Pittsburgh (UL1TR000005)
- University of Texas Southwestern (9U54TR000017)
- University of Utah (UL1TR000105-05)
- Vanderbilt University (UL1 TR000445)
- George Washington University (UL1TR000075)
- University of California, Davis (UL1 TR000002)
- University of Florida (UL1 TR000064)
- University of Michigan (UL1TR000433)
- Tulane University (P30GM103337 COBRE Award NIGMS)
- Wake Forest University (UL1TR001420)
This publication has 30 references indexed in Scilit:
- The Biomarker Promised Land: Are We There Yet? Not YetAmerican Journal of Kidney Diseases, 2022
- Metabolic Acidosis and Cardiovascular Disease in CKDKidney Medicine, 2021
- The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injuryKidney International, 2019
- A Randomized Trial of Intensive versus Standard Blood-Pressure ControlNew England Journal of Medicine, 2015
- Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial)American Journal of Kidney Diseases, 2015
- Urinary ammonia and long-term outcomes in chronic kidney diseaseKidney International, 2015
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CNew England Journal of Medicine, 2012
- Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African AmericansKidney International, 2011
- Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathyKidney International, 2010
- Chemical and hormonal determinants of vascular calcification in vitroKidney International, 2006